XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash cash equivalents and federal funds sold | 23.38%178.83M | 23.38%178.83M | 58.95%248.23M | 162.85%196.29M | 177.08%190.52M | 63.13%144.94M | 63.13%144.94M | 105.88%156.17M | -4.41%74.68M | -53.60%68.76M |
-Cash and cash equivalents | 23.44%177.34M | 23.44%177.34M | 59.86%247.3M | 166.24%195.01M | 181.60%189.28M | 64.13%143.66M | 64.13%143.66M | 106.63%154.7M | -4.43%73.25M | -34.61%67.22M |
-Money market investments | 16.51%1.5M | 16.51%1.5M | -36.64%932K | -10.47%1.28M | -19.68%1.24M | -3.02%1.28M | -3.02%1.28M | 48.59%1.47M | -3.44%1.43M | -96.60%1.55M |
Net loan | -0.73%2.54B | -0.73%2.54B | 0.37%2.51B | 1.76%2.54B | 3.97%2.52B | 9.45%2.56B | 9.45%2.56B | 17.91%2.51B | 23.35%2.49B | 24.16%2.42B |
-Gross loan | -0.65%2.57B | -0.65%2.57B | 0.24%2.54B | 1.72%2.56B | 3.91%2.54B | 9.48%2.58B | 9.48%2.58B | 18.00%2.53B | 23.45%2.52B | 24.32%2.45B |
-Allowance for loans and lease losses | 3.20%25.83M | 3.20%25.83M | 0.82%25.48M | 1.45%25.27M | 0.19%24.68M | 23.19%25.02M | 23.19%25.02M | 26.45%25.28M | 35.20%24.91M | 46.88%24.63M |
-Unearned income | -230.75%-676K | -230.75%-676K | 179.31%1.5M | 46.44%-1.02M | 34.66%-982K | 134.10%517K | 134.10%517K | -34.81%-1.89M | -22.94%-1.91M | 10.70%-1.5M |
Securities and investments | 17.40%440.96M | 17.40%440.96M | 14.96%419.91M | -0.22%379.93M | -5.79%362.26M | -6.23%375.62M | -6.23%375.62M | -9.53%365.25M | -6.77%380.76M | -9.00%384.52M |
-Available for sale securities | -15.98%14.4M | -15.98%14.4M | -11.57%15.03M | -16.05%14.72M | 27.73%14.74M | 74.90%17.14M | 74.90%17.14M | 106.58%17M | 100.74%17.54M | 34.72%11.54M |
-Short term investments | 18.99%426.56M | 18.99%426.56M | 16.26%404.88M | 0.55%365.21M | -6.83%347.52M | -8.27%358.48M | -8.27%358.48M | -11.94%348.26M | -9.12%363.23M | -9.91%372.98M |
Bank owned life insurance | 2.85%34.87M | 2.85%34.87M | 2.77%34.62M | 2.66%34.36M | 2.57%34.12M | 2.52%33.91M | 2.52%33.91M | 20.11%33.69M | 20.08%33.47M | 20.04%33.27M |
Net PPE | -5.50%33.83M | -5.50%33.83M | -2.74%33.81M | 5.68%34.55M | 15.78%35.02M | 24.91%35.8M | 24.91%35.8M | 31.28%34.77M | 23.39%32.69M | 13.47%30.24M |
-Gross PPE | -56.69%33.83M | -56.69%33.83M | -2.74%33.81M | 5.68%34.55M | 15.78%35.02M | 14.65%78.1M | 14.65%78.1M | 31.28%34.77M | 23.39%32.69M | 13.47%30.24M |
-Accumulated depreciation | ---- | ---- | ---- | ---- | ---- | -7.20%-42.3M | -7.20%-42.3M | ---- | ---- | ---- |
Goodwill and other intangible assets | 0.01%92.01M | 0.01%92.01M | -0.05%92M | -0.14%91.86M | 0.62%91.91M | 2.33%92.01M | 2.33%92.01M | 9.56%92.05M | 9.70%91.99M | 9.04%91.34M |
-Goodwill | 0.00%86.36M | 0.00%86.36M | 0.00%86.36M | 0.00%86.36M | 0.00%86.36M | 0.00%86.36M | 0.00%86.36M | 7.37%86.36M | 7.37%86.36M | 7.37%86.36M |
-Other intangible assets | 0.14%5.66M | 0.14%5.66M | -0.76%5.64M | -2.32%5.5M | 11.43%5.56M | 59.14%5.65M | 59.14%5.65M | 58.72%5.69M | 64.48%5.64M | 49.43%4.99M |
Other assets | 4.54%45.18M | 4.54%45.18M | -2.83%46.05M | 19.37%49.55M | 40.17%54.63M | 15.64%43.22M | 15.64%43.22M | 16.06%47.39M | 41.58%41.51M | 51.44%38.97M |
Total assets | 2.48%3.36B | 2.48%3.36B | 4.78%3.39B | 5.57%3.32B | 7.08%3.29B | 8.88%3.28B | 8.88%3.28B | 16.20%3.23B | 17.67%3.15B | 14.29%3.07B |
Liabilities | ||||||||||
Total deposits | 3.04%2.69B | 3.04%2.69B | 4.25%2.68B | 6.98%2.64B | 4.31%2.62B | 5.61%2.61B | 5.61%2.61B | 12.80%2.58B | 11.00%2.47B | 11.52%2.51B |
Federal funds purchased and securities sold under agreement to repurchase | -3.54%27.22M | -3.54%27.22M | -10.60%27.29M | -47.22%27.22M | -7.47%28.22M | -47.94%28.22M | -47.94%28.22M | -45.29%30.53M | -28.32%51.57M | -3.74%30.5M |
Payables | 0.74%3M | 0.74%3M | 5.64%3M | 4.98%2.98M | 5.09%2.98M | 5.01%2.97M | 5.01%2.97M | 4.07%2.84M | 7.92%2.83M | 14.99%2.83M |
-Dividends payable | 0.74%3M | 0.74%3M | 5.64%3M | 4.98%2.98M | 5.09%2.98M | 5.01%2.97M | 5.01%2.97M | 4.07%2.84M | 7.92%2.83M | 14.99%2.83M |
Long term debt and capital lease obligation | -6.52%280.87M | -6.52%280.87M | -1.03%297.87M | -0.20%300.86M | 46.45%291.36M | 74.61%300.45M | 74.61%300.45M | 105.15%300.96M | 290.68%301.46M | 104.77%198.94M |
-Long term debt | -6.52%280.87M | -6.52%280.87M | -1.03%297.87M | -0.20%300.86M | 46.45%291.36M | 74.61%300.45M | 74.61%300.45M | 105.15%300.96M | 290.68%301.46M | 104.77%198.94M |
Other liabilities | 14.79%31.66M | 14.79%31.66M | 86.52%40.83M | 53.08%27.83M | 37.33%25.93M | 43.36%27.58M | 43.36%27.58M | 46.80%21.89M | 0.63%18.18M | 27.81%18.88M |
Total liabilities | 2.12%3.03B | 2.12%3.03B | 4.17%3.05B | 5.53%3B | 7.44%2.97B | 9.18%2.97B | 9.18%2.97B | 17.11%2.93B | 18.75%2.84B | 15.20%2.76B |
Shareholders'equity | ||||||||||
Share capital | 0.04%135.57M | 0.04%135.57M | 0.02%135.19M | 0.13%135.83M | 0.18%135.48M | 0.01%135.52M | 0.01%135.52M | 10.97%135.17M | 10.15%135.65M | 10.05%135.24M |
-common stock | 0.04%135.57M | 0.04%135.57M | 0.02%135.19M | 0.13%135.83M | 0.18%135.48M | 0.01%135.52M | 0.01%135.52M | 10.97%135.17M | 10.15%135.65M | 10.05%135.24M |
Retained earnings | 6.68%235.85M | 6.68%235.85M | 5.47%230.47M | 4.71%226.43M | 4.99%223.65M | 4.06%221.08M | 4.06%221.08M | 5.03%218.51M | 7.68%216.24M | 9.21%213.01M |
Less: Treasury stock | -0.50%10.99M | -0.50%10.99M | -0.94%10.9M | -2.58%11.01M | -4.06%10.85M | -4.61%11.04M | -4.61%11.04M | -4.67%11.01M | -4.43%11.3M | -3.65%11.31M |
Gains losses not affecting retained earnings | 13.06%-25.22M | 13.06%-25.22M | 50.94%-19.37M | 20.41%-28.59M | 1.91%-30.59M | 24.12%-29.01M | 24.12%-29.01M | -4.64%-39.49M | -14.91%-35.92M | -58.10%-31.19M |
Total stockholders'equity | 5.90%335.21M | 5.90%335.21M | 10.62%335.38M | 5.91%322.66M | 3.90%317.69M | 6.17%316.54M | 6.17%316.54M | 8.06%303.18M | 8.47%304.66M | 6.73%305.76M |
Total equity | 5.90%335.21M | 5.90%335.21M | 10.62%335.38M | 5.91%322.66M | 3.90%317.69M | 6.17%316.54M | 6.17%316.54M | 8.06%303.18M | 8.47%304.66M | 6.73%305.76M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |